Tarrytown, NY - 21 March 2020 - Entrance to Regeneron Pharmaceuticals, a biotech company that hopes to start clinical trials this summer of a cocktail therapy of antibodies to Covid-19, which can either be administered to at-risk people as a vaccine befor

Tarrytown, NY - 21 March 2020 - Entrance to Regeneron Pharmaceuticals, a biotech company that hopes to start clinical trials this summer of a cocktail therapy of antibodies to Covid-19, which can either be administered to at-risk people as a vaccine before exposure or as treatment for those infected. Earlier this week Regeneron and Sanofi announced the launch of clinical trials of Kevzara, a biologic drug they developed for rheumatoid arthritis, for use against the novel coronavirus. Regeneron begins US drug trials in hard hit New York, Sanofi in Italy and other hard hit areas outside the US